These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20074598)

  • 1. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.
    Batrakova EV; Li S; Brynskikh AM; Sharma AK; Li Y; Boska M; Gong N; Mosley RL; Alakhov VY; Gendelman HE; Kabanov AV
    J Control Release; 2010 May; 143(3):290-301. PubMed ID: 20074598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.
    Hong W; Chen D; Zhang X; Zeng J; Hu H; Zhao X; Qiao M
    Biomaterials; 2013 Dec; 34(37):9602-14. PubMed ID: 24021757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
    Sharma AK; Zhang L; Li S; Kelly DL; Alakhov VY; Batrakova EV; Kabanov AV
    J Control Release; 2008 Nov; 131(3):220-7. PubMed ID: 18722489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells.
    Minko T; Batrakova EV; Li S; Li Y; Pakunlu RI; Alakhov VY; Kabanov AV
    J Control Release; 2005 Jul; 105(3):269-78. PubMed ID: 15939500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluronics and MDR reversal: an update.
    Alakhova DY; Kabanov AV
    Mol Pharm; 2014 Aug; 11(8):2566-78. PubMed ID: 24950236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.
    Alakhova DY; Rapoport NY; Batrakova EV; Timoshin AA; Li S; Nicholls D; Alakhov VY; Kabanov AV
    J Control Release; 2010 Feb; 142(1):89-100. PubMed ID: 19815037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.
    Kabanov AV; Batrakova EV; Alakhov VY
    J Control Release; 2003 Aug; 91(1-2):75-83. PubMed ID: 12932639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells.
    Batrakova E; Lee S; Li S; Venne A; Alakhov V; Kabanov A
    Pharm Res; 1999 Sep; 16(9):1373-9. PubMed ID: 10496652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
    Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
    Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion.
    Batrakova EV; Li S; Elmquist WF; Miller DW; Alakhov VY; Kabanov AV
    Br J Cancer; 2001 Dec; 85(12):1987-97. PubMed ID: 11747344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluronic block copolymers for overcoming drug resistance in cancer.
    Kabanov AV; Batrakova EV; Alakhov VY
    Adv Drug Deliv Rev; 2002 Sep; 54(5):759-79. PubMed ID: 12204601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage.
    Lee Y; Park SY; Mok H; Park TG
    Bioconjug Chem; 2008 Feb; 19(2):525-31. PubMed ID: 18163537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity.
    Batrakova EV; Dorodnych TY; Klinskii EY; Kliushnenkova EN; Shemchukova OB; Goncharova ON; Arjakov SA; Alakhov VY; Kabanov AV
    Br J Cancer; 1996 Nov; 74(10):1545-52. PubMed ID: 8932333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.
    Batrakova EV; Li S; Alakhov VY; Elmquist WF; Miller DW; Kabanov AV
    Pharm Res; 2003 Oct; 20(10):1581-90. PubMed ID: 14620511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B; Zhang H; Yu L
    Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.